Beerse, Belgium

Nicolaas Martha Felix Goyvaerts

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nicolaas Martha Felix Goyvaerts: Innovator in Pharmaceutical Compositions

Introduction

Nicolaas Martha Felix Goyvaerts is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating various medical conditions. With a total of 2 patents to his name, Goyvaerts has demonstrated a commitment to innovation in healthcare.

Latest Patents

Goyvaerts' latest patents include "Compositions comprising aticaprant," which relates to oral compositions in the form of tablets that include aticaprant and methods of using the same. Another significant patent is for "Dispersible compositions," which focuses on dispersible compositions containing rilpivirine or a pharmaceutically acceptable acid addition salt as an active ingredient. These compositions are particularly useful in the treatment of HIV infection, especially among pediatric and geriatric populations due to their dispersibility properties.

Career Highlights

Throughout his career, Goyvaerts has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceuticals, Inc. and Janssen Sciences Ireland Unlimited Company. His work has contributed to advancements in drug formulations and patient care.

Collaborations

Goyvaerts has collaborated with several professionals in his field, including Mark Schmidt and Vanina Popova. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical compositions.

Conclusion

Nicolaas Martha Felix Goyvaerts is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact on the treatment of HIV and other medical conditions. His patents reflect a dedication to improving patient outcomes through innovative drug formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…